What is your Payment Terms?

By T/T 30% advance payment and 70% paid on the B/L copy or L/C at sight.

Industrial Grade Animal Bone Ash for Bone China or Ceramics

Name: Industrial Grade Animal Bone Ash for Bone China or Ceramics
Brand: Xiamen Gelken Gelatin Co., Ltd.
SKU: 1928757005

Fujian, ChinaXiamen Gelken Gelatin Co., Ltd.

US$1.30

1-999 kg

US$1.25

1,000-15,999 kg

US$1.20

16,000+ kg

Sample price:US$1.20/kg.Request sample

Product profile

Customization

Available

CAS No.

68439-86-1

Appearance

Powder

Usage

Water Treatment Chemicals, Coating Auxiliary Agents

Color

White

Product Name

Animal Bone Ash

Raw Material

Animal Bone

Ingredients

Calcium Hydrogen Phosphate

Transport Package

25kg/Bag, Kraft Paper Bag Outside and PE Bag Insid

Specification

25kg/bag

Trademark

Gelken

Origin

China

HS Code

3802900090

Production Capacity

5000 Tons Per Year

Key features

Versatile Applications: Used in ceramics, opal glass, pigment stabilizer, polishing, and water treatment.

Certified Manufacturer: ISO22000, HALAL, HACCP certified with 20 years of professional experience.

Large Production Capacity: Annual production reaches 12,000 metric tons ensuring stable supply.

Secure Packaging: 25kg/bag with kraft paper outside and PE bag inside for protection.

Company profile

Exhibition ExperienceYears of Export ExperienceManagement CertificationHigh Repeat Buyers Choice

Xiamen Gelken Gelatin Co., Ltd.

Fujian, China

Business Type: Manufacturer/FactoryExport Year: 2011-05-18Nearest Port: XIAMEN PORT, CHINA, SHANGHAI PORT, SHENZHEN PORTAverage Response Time: ≤3.29hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryXiamen Gelken Gelatin Co., Ltd. is identified as a China-based manufacturer/factory engaged in health, medicine, chemicals, and food-related products. The supplier offers gelatin, collagen, and related materials, with stated production facilities, five production lines, 50 quality-control staff, and certifications including ISO 9001, ISO 22000, GMP, and HACCP; HALAL is also stated in the company description. It holds stated drug and edible production licenses and has exported since 2011, with exports representing 90% of total sales and self-operated import/export rights. An SGS audit record is available for March 3, 2025 to March 2, 2026, but the recorded evaluation result is not explained. Evidence is insufficient for after-sales service, financial credibility, innovation, customization, and customer cases. Production information is positive but includes differing stated gelatin and total output figures across records, which should be reconciled.

Supplier typeThe supplier is identified as both a Manufacturer/Factory and a limited company, with its business associated with health and medicine, chemicals, and agriculture and food. A separate record labels the associated-company industry as wholesale and retail, but the direct supplier classification is manufacturer/factory.

CertificationsThe supplier states ISO 22000, ISO 9001, GMP, HALAL, and HACCP compliance, while another record confirms ISO 9001, ISO 22000, GMP, and HACCP. It also states possession of drug and edible production licenses, and an SGS audit record covers March 3, 2025 through March 2, 2026; however, the audit result code is not explained.

Production capacityThe supplier states production of gelatin, collagen, and related products, with five production lines, 50 quality-control staff, and reported outputs of 30,000 tons of jelly glue, 15,000 tons of gelatin, and 5,000 tons of collagen. The company description separately states annual production of 12,000 metric tons, and inventory, outsourcing procedures, capacity reconciliation, and valid manufacturing contracts are marked unknown, so capacity evidence is positive but internally inconsistent.

Customization capabilityThe company states it can provide gelatin with different applications according to customer requirements. Nevertheless, ODM, OEM, 3D design, and new-product development capabilities are marked unknown, so the evidence supports application-related flexibility but not a broader customization capability assessment.